Approval · Notice of Compliance 18690 · 2016
BYETTA: Notice of Compliance 18690
Issued November 21, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18690
- Date
- November 21, 2016
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Use of an alternate autoclave (ac12)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BYETTA | Not yet assigned | — |
Medicinal ingredients
- EXENATIDE 0.25 MG per ML